Filing a Risperdal Lawsuit
If you or a loved one has taken Risperdal (Risperidone) and developed gynecomastia (male breast growth), you may be eligible to file a Risperdal (Risperidone) lawsuit.
A Risperdal lawsuit can help to compensate for the for the pain, suffering, surgical expenses, hospital bills, and embarrassment that Risperdal victims have suffered. Jensen & Associates, has successfully represented hundreds of people with claims against drug and device companies. We would be pleased to evaluate your case.
Risperdal is the brand name for the drug risperidone. Made and sold by the Johnson & Johnson subsidiary Ortho-McNeil-Janssen, this prescription medication is used to treat schizophrenia in teenagers and adults, Bipolar I Disorder in those aged 10 and older, and irritability associated with autistic disorder in children aged 5-16 years.
The U.S. Food and Drug Administration (FDA) approved Risperdal in late 1993. Sales of Risperdal peaked in 2007 at more than $4.5 billion in 2007. After the drug lost patent protection, sales of Risperdal fell to $358 million by 2012.
Like other atypical antipsychotics, Risperdal targets the serotonin and dopamine receptors in the brain. The drug has been linked to a number of serious side effects, including Risperdal gynecomastia, diabetes, and movement disorders.
Since its approval, a number of studies have pointed to a link between the use of Risperdal and male breast development. Many Risperdal lawsuits have been filed around the country that allege Johnson & Johnson and its Janssen unit were aware that Risperdal could cause gynecomastia, but concealed that knowledge from the public. It has been alleged that Johnson & Johnson failed to provide adequate warnings about the risks and failed to properly research the side effects of the drug. The government has also charged that Johnson & Johnson had illegally promoted the use of Risperdal for children long before it had been approved for any pediatric indications.
If you or a loved one has suffered injury or loss from taking Risperdal contact us for a free case evaluation.